| Developers: | DNA Technology |
| Date of the premiere of the system: | 2023/01/27 |
| Branches: | Pharmaceuticals, Medicine, Healthcare |
2023: Reagent Kit Development
The metropolitan company "DNA-Technology" has developed three types of tests to assess the risk of giving birth to a child with hereditary diseases. This was announced on January 27, 2023 by the head of the Department of Investment and Industrial Policy of Moscow, which is part of the Complex of Economic Policy and Property and Land Relations of the capital, Vladislav Ovchinsky.
The reagent kit "NeoScreen SMA/TREC/KREC" allows you to identify the most common genetic diseases in newborns that pose a threat to the life and health of the child. This kit is designed to screen newborns for spinal muscular atrophy and primary immunodeficiency. The study is carried out using dry spots of capillary blood plotted on neonatal screening maps by real-time PCR and meets all the requirements necessary for inclusion in the neonatal screening program. Read more here.
See also
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |